Sign in

CIK 0001503802

  • Non-accelerated filer
  • Smaller reporting company

Karyopharm Therapeutics Inc.

Sign in to watch
Tickers
KPTI KPTIQ
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
263931704
Phone
+1 617-658-0600
Business address
85 WELLS AVENUE, SECOND FLOOR, NEWTON, MA, 02459

Securities

  • KPTI Common stock Nasdaq
  • KPTIQ Common stock
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$2,135
in 3 filings

Net −$2,135. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Abate Kristin −$2K Chief Accounting Officer sold 22% of stake

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2022-02-28 Mason Michael EVP, CFO & Treasurer Sale −2,398 $10.24 $25K 139,110
2022-02-28 Mason Michael EVP, CFO & Treasurer Grant or award · Stock Option (right to buy) +111,600 111,600
2022-02-28 Shacham Sharon Chief Scientific Officer Sale −6,226 $10.24 $64K 898,131
2022-02-28 Shacham Sharon Chief Scientific Officer Grant or award +21,000 719,983
2022-02-28 Shacham Sharon Chief Scientific Officer Sale −6,226 $10.24 $64K 713,757
2022-02-28 Shacham Sharon Chief Scientific Officer Grant or award · Stock Option (right to buy) +27,000 27,000
2022-02-28 Kauffman Michael Director Grant or award +21,000 719,983
2022-02-28 Kauffman Michael Director Sale −6,226 $10.24 $64K 713,757
2022-02-28 Kauffman Michael Director Sale −6,226 $10.24 $64K 898,131
2022-02-28 Kauffman Michael Director Grant or award · Stock Option (right to buy) +27,000 27,000
2022-02-28 Mitchener Stephen SVP, Chief Business Officer Grant or award +47,250 50,546
2022-02-28 Mitchener Stephen SVP, Chief Business Officer Grant or award · Stock Option (right to buy) +59,400 59,400
2022-02-28 Cheng Sohanya Roshan Chief Commercial Officer Grant or award +84,000 91,500
2022-02-28 Cheng Sohanya Roshan Chief Commercial Officer Grant or award · Stock Option (right to buy) +108,000 108,000
2022-02-28 Mano Michael SVP, General Counsel&Secretary Grant or award +63,000 63,000
2022-02-28 Mano Michael SVP, General Counsel&Secretary Grant or award · Stock Option (right to buy) +81,000 81,000
2022-02-28 Paulson Richard A. President and CEO Grant or award +288,750 661,950
2022-02-28 Paulson Richard A. President and CEO Grant or award · Stock Option (right to buy) +360,000 360,000
2022-02-17 Shah Jatin EVP, Chief Medical Officer Sale −1,306 $12.12 $16K 129,450
2022-02-17 Frenkel Ran EVP, Chief Dev. Officer Sale −2,929 $12.12 $36K 101,703

Page 14 of 15 · 287 trades